XCUR
ExicureCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The equity already trades like a distressed option on financing or a strategic transaction, so confirmation that the GPCR program is still being funded and advanced could produce outsized upside from a low base. The May 29, 2026 10-Q also shows the asset remains active rather than abandoned [#SEC-10Q-2026-05-29].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Dilution risk remains high because the most likely funding path appears to be equity issuance, and the planned $1.0 million GPCR milestone payment is expected to be made in stock [#SEC-10Q-2026-05-29].
Momentum
88
Value
41
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.80 · Bull $3.20 · Bear $0.80
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-30 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Why
Momentum88 · Δ7d -
Value41 · Δ7d +0.0
Sentiment43 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
88
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
43
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 87.9 / Value 41.1 / Sentiment 42.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$12.05M
Beta
4.11
Shares Out
6.37M
P/E (TTM) · Derived
-2.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.48
Rev YoY
-100.0%
EPS YoY
-158.9%
Gross Margin
-64.8%
Op Margin
-2365.0%
Net Debt
-$3.57M
Current Ratio
0.79
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology